Evidence map›Paper›PMID 23792540›Full record

ArticlePharmacology, biochemistry, and behavior2013

Adolescent binge-like ethanol exposure reduces basal α-MSH expression in the hypothalamus and the amygdala of adult rats.

Jose Manuel Lerma-Cabrera, Francisca Carvajal, Manuel Alcaraz-Iborra, Leticia de la Fuente, Montserrat Navarro, Todd E Thiele, Inmaculada Cubero

Abstract read
In one paragraph

Article in Pharmacology, biochemistry, and behavior, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Neuronal modulation of hepatic lipid accumulation induced by bingelike drinking.American journal of physiology. Endocrinology and metabolism · 2020
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Synaptic changes induced by melanocortin signalling.Nature reviews. Neuroscience · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jose Manuel Lerma-CabreraDepartamento de Neurociencia y Ciencias de la Salud, Universidad de Almería, Almería 04120, Spain.
Francisca Carvajal
Manuel Alcaraz-Iborra
Leticia de la Fuente
Montserrat Navarro
Todd E Thiele
Inmaculada Cubero
University of Almería · ESUniversity of North Carolina at Chapel Hill · US

Funding

Neuropeptide Y: Role in Ethanol Intake and SensitivityR01AA013573 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI THIELE, TODD ERIC · 2001 to 2018
$3.8M
Neuropeptide Y: Role in Ethanol Intake and SensitivityR37AA013573 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TODD Eric THIELE · 2019 to 2026
$3.0M
Melanocortin Neuropeptides &Ethanol IntakeR01AA015148 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI THIELE, TODD ERIC · 2005 to 2014
$2.5M
NIAAA NIH HHS AA013573NIAAA NIH HHS AA015148NIAAA NIH HHS R01 AA013573NIAAA NIH HHS R01 AA015148NIAAA NIH HHS R37 AA013573
6 · The paper itself

Abstract

Melanocortins (MC) are central peptides that have been implicated in the modulation of ethanol consumption. There is experimental evidence that chronic ethanol exposure reduces α-MSH expression in the limbic and hypothalamic brain regions and alters central pro-opiomelanocortin (POMC) mRNA activity in adult rats. Adolescence is a critical developmental period of high vulnerability in which ethanol exposure alters corticotropin releasing factor, neuropeptide Y, substance P and neurokinin neuropeptide activities, all of which have key roles in ethanol consumption. Given the involvement of MC and the endogenous inverse agonist AgRP in ethanol drinking, here we evaluate whether a binge-like pattern of ethanol treatment during adolescence has a relevant impact on basal and/or ethanol-stimulated α-MSH and AgRP activities during adulthood. To this end, adolescent Sprague-Dawley rats (beginning at PND25) were pre-treated with either saline (SP group) or binge-like ethanol exposure (BEP group; 3.0 g/kg given in intraperitoneal (i.p.) injections) of one injection per day over two consecutive days, followed by 2 days without injections, repeated for a total of 8 injections. Following 25 ethanol-free days, we evaluated α-MSH and AgRP immunoreactivity (IR) in the limbic and hypothalamic nuclei of adult rats (PND63) in response to ethanol (1.5 or 3.0 g/kgi.p.) and saline. We found that binge-like ethanol exposure during adolescence significantly reduced basal α-MSH IR in the central nucleus of the amygdala (CeA), the arcuate nucleus (Arc) and the paraventricular nucleus of the hypothalamus (PVN) during adulthood. Additionally, acute ethanol elicited AgRP IR in the Arc. Rats given the adolescent ethanol treatment required higher doses of ethanol than saline-treated rats to express AgRP. In light of previous evidence that endogenous MC and AgRP regulate ethanol intake through MC-receptor signaling, we speculate that the α-MSH and AgRP disturbances induced by binge-like ethanol exposure during adolescence may contribute to excessive ethanol consumption during adulthood.

Indexed as

Age Factorsalpha-MSHAmygdalaAnimalsBody WeightEthanolHypothalamusRatsRats, Sprague-Dawleyalpha-MSHEthanolAA AlkoAdolescentsagouti-related peptideAgRPAgRP immunoreactivityalcohol-preferring ratsalcohol ratsANA AlkoArcBECbed nucleus of the stria terminalisBEPBinge-like ethanolbinge-like ethanol pre-treatment groupblood ethanol concentrationBNSTbody weightBWCeAcentral nucleus of amygdalacorticotropin releasing factorCRFDMHdorsomedial nucleus of the hypothalamusHPAhypothalamic arcuate nucleushypothalamic–pituitary–adrenal axisIHCimmunohistochemistryimmunoreactivityIRlateral hypothalamusLHMCMC-RMC receptorsmelanocortinmelanotan-IIMTIINAcnon alcohol ratsnucleus accumbensPparaventricular nucleus of the hypothalamusPC1/3PNDPOMCpostnatal daypro-hormone convertase 1/3pro-opiomelanocortinPVNsaline pre-treatment groupSPventral tegmental areaventromedial nucleus of the hypothalamusVMHVTAα-melanocyte stimulating hormoneα-MSHβ-melanocyte stimulating hormoneβ-MSHγ-melanocyte stimulating hormoneγ-MSH

Identifiers

PMID23792540
PMCPMC3805790
OpenAlexW1997520043

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.